Food debris found on equipment, FDA says

FDA finds little handwashing, dirty equipment at McDonald's supplier linked to E. coli outbreak
More than a hundred E. coli cases were linked to contaminated onions produced by Taylor Farms used in McDonald's burgers.
McDonald's E. Coli outbreak: Food debris found on equipment, FDA says
The FDA released new information about the deadly E. coli outbreak linked to McDonald's Quarter Pounders. According to the FDA, food debris was found on equipment supposedly fully cleaned at the Taylor Farms food production facility in Colorado that supplied slivered onions used at McDonald's.
‘E coli’ outbreak linked to McDonald’s Quarter Pounder ends
Last month, the US Centres for Disease Control and Prevention (CDC) said that an E coli outbreak has ended. It was connected to McDonald’s Quarter Pounder hamburgers. As of December 3, the CDC said 104 people fell ill and 34 were hospitalised because of the E coli outbreak.
FDA finds little handwashing, dirty equipment at McDonald's supplier linked to outbreak
More than a hundred E. coli cases were linked to contaminated onions produced by Taylor Farms used in McDonald's burgers.
Unwashed hands caused McDonald's E.coli outbreak: FDA
The FDA discovered infrequent handwashing and dirty equipment were the culprits of the deadly E.coli outbreak that impacted a McDonald's supplier. According to reports, the FDA found food sanitation procedure violations at Taylor Farms' food production facility in Colorado.
FDA Releases Bombshell Report in McDonald's Deadly Ecoli Outbreak
A newly released report from the Food and Drug Administration (FDA) has revealed widespread sanitation failures at Taylor Farms Colorado, Inc., a key supplier for McDonald's, following an E. coli outbreak that claimed the life of an elderly man and left hundreds of others ill.
Food debris found on equipment linked to deadly E. coli outbreak
According to the FDA, food debris was found on equipment supposedly fully cleaned at the Taylor Farms food production facility in Colorado supplying slivered onions used at McDonald's.
STAT2d
Patrizia Cavazzoni, head of FDA’s drug center, to leave the agency
Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.
FDA Approves Weight-loss Drug Zepbound For Sleep Apnea – Will Insurance Cover This $1000-Per-Month Medication?
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Biden FDA moves forward with rule to lower nicotine in cigarettes, a ‘gift’ to cartels, critic says
Opponents argue that the change could cause current smokers to use more cigarettes to compensate for the lower nicotine ...
FiercePharma2d
FDA's Patrizia Cavazzoni to retire as CDER chief in 2nd senior official's departure in span of weeks
The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire ...
STAT2d
In debate over obesity medications, FDA shifts toward importance of drugs in subtle ways
The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...
BioPharma Dive2d
Patrizia Cavazzoni, key FDA official, to leave agency
The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...
FDA issues draft guidance to improve accuracy of pulse oximeters for people with darker skin tones
Years of research have showed that pulse oximeters yield less accurate readings for people with darker skin tones, and now ...
Drug to treat rare pediatric disease accepted for FDA review
A subsidiary of a Miami-based company is inching closer to FDA approval for a drug that treats a rare pediatric disease.
FDA sets limits on lead in some baby foods
But consumer advocates say the Food and Drug Administration's new guidance on lead limit in baby food doesn't go far enough.
Cure Today1d
A Breakdown of Trial Data that Led to the Subcutaneous Opdivo FDA Approval
Dr. Eric K. Singhi discusses the significance of the FDA approval of subcutaneous Opdivo for patients with solid tumors.